/ Print /

Editor's Choice MHE

Top 10 healthcare wearables to watch
Top 10 healthcare wearables to watchInnovation in healthcare wearables continues to drive market growth.
Cannabinoid-based drug pipeline shows promise
Cannabinoid-based drug pipeline shows promiseNew treatment indications are under investigation for the use of cannabinoid-based drugs.
Four priorities your health plan must embrace to thrive in the future
Four priorities your health plan must embrace to thrive in the futureHealth plans of the future will focus on consumers: designing products, care and services to support improved health.
New strategies for managing drug spend: RA, Cancer, Hep C
New strategies for managing drug spend: RA, Cancer, Hep CThe proliferation of specialty drugs has prompted new techniques for keeping costs in tow.
Six diseases reap benefits of biomarkers, genetic tests
Six diseases reap benefits of biomarkers, genetic testsBiomarker testing for harmful genetic mutations provides the opportunity to identify at-risk individuals who might benefit from risk modification strategies and/or enhanced disease screening.
Four tech trends in healthcare in 2017
Four tech trends in healthcare in 2017Several changes and transitions will have a huge impact on health IT in 2017 and in future years.
Four ways tech improves chronic disease management
Four ways tech improves chronic disease managementFinding technology solutions to diagnose and manage chronic conditions is critical to the future of healthcare.
Top four healthcare industry changes to watch in 2017
Top four healthcare industry changes to watch in 2017In order to survive as a managed care organization, it’s important to stay on top of policy changes and reimbursement trends.
Do physicians dismiss patients’ financial concerns?
Do physicians dismiss patients’ financial concerns?Patients need cost information to make the best treatment decisions. But physicians are coming up short.
Watch list 2017: Top therapeutic areas
Watch list 2017: Top therapeutic areasFind out about the latest treatment and drug pipeline developments